Cibc World Markets Corp grew its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 15.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 78,648 shares of the real estate investment trust's stock after buying an additional 10,508 shares during the period. Cibc World Markets Corp's holdings in Omega Healthcare Investors were worth $2,977,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently made changes to their positions in OHI. Harbour Investments Inc. lifted its holdings in Omega Healthcare Investors by 18.4% during the 4th quarter. Harbour Investments Inc. now owns 7,817 shares of the real estate investment trust's stock valued at $296,000 after purchasing an additional 1,215 shares during the last quarter. Envestnet Portfolio Solutions Inc. raised its position in shares of Omega Healthcare Investors by 17.0% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 14,239 shares of the real estate investment trust's stock valued at $539,000 after purchasing an additional 2,073 shares during the period. Natixis Advisors LLC lifted its stake in shares of Omega Healthcare Investors by 9.5% during the 4th quarter. Natixis Advisors LLC now owns 34,736 shares of the real estate investment trust's stock worth $1,315,000 after buying an additional 3,025 shares during the last quarter. Frank Rimerman Advisors LLC boosted its holdings in shares of Omega Healthcare Investors by 18.3% during the 4th quarter. Frank Rimerman Advisors LLC now owns 17,173 shares of the real estate investment trust's stock worth $650,000 after buying an additional 2,660 shares during the period. Finally, Midwest Professional Planners LTD. grew its stake in Omega Healthcare Investors by 14.9% in the 4th quarter. Midwest Professional Planners LTD. now owns 38,665 shares of the real estate investment trust's stock valued at $1,463,000 after buying an additional 5,021 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on OHI. BMO Capital Markets upgraded Omega Healthcare Investors from a "market perform" rating to an "outperform" rating and set a $45.00 price objective for the company in a report on Monday, December 9th. Truist Financial upped their price objective on Omega Healthcare Investors from $38.00 to $39.00 and gave the company a "hold" rating in a report on Tuesday, March 18th. Mizuho lifted their target price on Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a "neutral" rating in a report on Thursday, December 5th. JMP Securities restated a "market perform" rating on shares of Omega Healthcare Investors in a research note on Friday, February 7th. Finally, Wells Fargo & Company lowered their price target on shares of Omega Healthcare Investors from $43.00 to $41.00 and set an "overweight" rating on the stock in a research report on Monday, March 10th. Five equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $42.25.
View Our Latest Stock Analysis on OHI
Omega Healthcare Investors Price Performance
Shares of OHI traded down $0.49 during mid-day trading on Tuesday, reaching $37.51. The company had a trading volume of 1,991,107 shares, compared to its average volume of 1,693,584. The company has a market capitalization of $10.57 billion, a price-to-earnings ratio of 24.20, a P/E/G ratio of 1.09 and a beta of 1.00. The company has a debt-to-equity ratio of 1.02, a quick ratio of 7.07 and a current ratio of 7.07. The company's 50 day simple moving average is $37.09 and its 200 day simple moving average is $38.86. Omega Healthcare Investors, Inc. has a 1-year low of $29.66 and a 1-year high of $44.42.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The real estate investment trust reported $0.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.41 by $0.33. Omega Healthcare Investors had a net margin of 38.65% and a return on equity of 9.71%. Analysts expect that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.
Omega Healthcare Investors Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, February 18th. Stockholders of record on Monday, February 10th were issued a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a dividend yield of 7.14%. The ex-dividend date of this dividend was Monday, February 10th. Omega Healthcare Investors's dividend payout ratio (DPR) is currently 172.90%.
About Omega Healthcare Investors
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Featured Stories

Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.